Contact
About Us
Products & Technology
Back
LungFit PH
Pipeline
News & Events
Back
Press Releases
Presentations & Publications
Events
Investors
Back
Stock Data
SEC Filings
Governance
Careers
Contact
Press Releases
Stay
Notified
Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
September 23, 2024
Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update
August 6, 2024
Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia
July 31, 2024
Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6
July 23, 2024
Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024
July 16, 2024
Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
June 24, 2024
Beyond Air® Appoints David Webster as Chief Commercial Officer
June 13, 2024
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
June 3, 2024
Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
May 23, 2024
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting
May 1, 2024
Posts navigation
1
2
…
15
Next
Sign up for updates from Beyond Air, Inc.
Unsubscribe from all email communications.
Unsubscribe